Actively Recruiting
A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population
Led by Bragg Live Food Products · Updated on 2026-03-06
24
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
Sponsors
B
Bragg Live Food Products
Lead Sponsor
K
KGK Science Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical study is to investigate the efficacy of a Bragg Apple Cider Vinegar (ACV) liquid on postprandial glucose (PPG) excursion compared to a placebo following a standardized acute carbohydrate load. The main question it aims to answer is: Is there a difference in the incremental area under the curve (iAUC) (from 0 - 120 mins following administration) for venous blood glucose between Bragg ACV liquid and placebo following an acute carbohydrate load. Participants will \[describe the main tasks participants will be asked to consume 750 mg of Bragg Apple Cider Vinegar (ACV) liquid or water and undergo a blood draw to measure glucose, insulin, and future analysis markers.
CONDITIONS
Official Title
A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged 20 to 50 years, inclusive
- Females not of child-bearing potential (sterilized or post-menopausal for at least 1 year) OR females of child-bearing potential with negative pregnancy test and using approved birth control for study duration
- Hormonal birth control use for at least 3 months if applicable
- Acceptable birth control methods include hormonal contraceptives, double-barrier method, intrauterine devices, vasectomy of partner (≥6 months), abstinence with agreement to use contraception if sexually active
- Elevated fasting glucose >5.6 mmol/L but <7.0 mmol/L and/or HbA1c between 6.0-6.4% with two or more markers of metabolic syndrome
- Stable body weight with less than 5% change in past 3 months
- Agreement to maintain current lifestyle habits and comply with dietary guidelines
- Provided voluntary, written informed consent
- Otherwise healthy as determined by medical history and lab results
You will not qualify if you...
- Pregnant, breastfeeding, or planning pregnancy during the study
- Allergy, sensitivity, or intolerance preventing consumption of study products or standardized meal
- Poor venous access
- Current use of medications, supplements, or foods that affect glucose metabolism or investigational product efficacy
- Unstable metabolic or chronic diseases
- Current or history of significant gastrointestinal diseases
- Unstable hypertension unless on stable medication for at least 3 months
- Diagnosis of Type I or Type II diabetes
- Significant cardiovascular event in past 6 months unless stable on medication
- History or diagnosis of kidney or liver disease except symptom-free kidney stones for 6 months
- Thyroid condition unless stable on medication for at least 3 months
- Major surgery in past 3 months or planned surgery during study
- Cancer except basal cell carcinoma excised with no chemo/radiation or cancer in remission >5 years
- Autoimmune diseases or immune compromise
- HIV, Hepatitis B or C infection
- Blood or bleeding disorders
- Regular cannabinoid use (>1 time/month); occasional users must abstain during study
- Regular tobacco or nicotine use in past 6 months; occasional users must abstain
- Alcohol intake >2 standard drinks per day
- Alcohol or drug abuse within last 12 months
- Significant abnormal lab results at screening
- Blood donation within 30 days before baseline or planned during study
- Participation in other clinical studies within 30 days before baseline
- Unable to give informed consent
- Any other condition or lifestyle factor that may affect study completion or pose risk per investigator opinion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
KGK Science Inc.
London, Ontario, Canada, N6B3L1
Actively Recruiting
Research Team
M
Marc Moulin, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here